VEGFA and gastric cancer: On the contrary, in breast cancer cells, MSC-EVs carrying miR-100 are reported to suppress angiogenesis by decreasing the expression of VEGF, while MSC-EVs are reported to enhance VEGF expression in gastric cancer cells [81,82].